DAFNA Capital Management LLC - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 50 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$375,000
-75.2%
191,494
-7.0%
0.16%
-70.0%
Q4 2019$1,515,000
-10.6%
205,825
-45.1%
0.52%
-18.4%
Q3 2019$1,695,000
-54.7%
375,0000.0%0.64%
-54.7%
Q2 2019$3,739,000375,0001.40%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,930,092$1,363,0000.55%
AMERICAN FINANCIAL GROUP INC 1,480,000$1,045,0000.29%
Vanguard Capital Wealth Advisors 158,900$111,0000.08%
Anson Funds Management LP 553,652$391,0000.04%
Nantahala Capital Management 894,659$632,0000.02%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$1,479,0000.02%
Harel Insurance Investments & Financial Services Ltd. 1,176,401$831,0000.02%
Atom Investors LP 113,151$80,0000.01%
Virtu Financial LLC 130,270$91,0000.01%
Altshuler Shaham Ltd 1,157,540$828,0000.01%
View complete list of ELOXX PHARMACEUTICALS INC shareholders